The newly approved product is a generic therapeutic equivalent version of GlaxoSmithKline's Imitrex Nasal Spray.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3sGLvmo
via IFTTT
Home »
Healthcare/Biotech-Industry-Economic Times
» Cipla gets USFDA nod for migraine drug
0 comments:
Post a Comment